224 related articles for article (PubMed ID: 33738427)
21. A Quantitative Chloride Channel Conductance Assay for Efficacy Testing of AAV.BEST1.
Wood SR; McClements ME; Martinez-Fernandez de la Camara C; Patrício MI; Uggenti C; Sekaran S; Barnard AR; Manson FD; MacLaren RE
Hum Gene Ther Methods; 2019 Apr; 30(2):44-52. PubMed ID: 30963787
[TBL] [Abstract][Full Text] [Related]
22.
Guziewicz KE; Cideciyan AV; Beltran WA; Komáromy AM; Dufour VL; Swider M; Iwabe S; Sumaroka A; Kendrick BT; Ruthel G; Chiodo VA; Héon E; Hauswirth WW; Jacobson SG; Aguirre GD
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2839-E2848. PubMed ID: 29507198
[TBL] [Abstract][Full Text] [Related]
23. Induced Pluripotent Stem Cell Modeling of Best Disease and Autosomal Recessive Bestrophinopathy.
Lee JH; Oh JO; Lee CS
Yonsei Med J; 2020 Sep; 61(9):816-825. PubMed ID: 32882766
[TBL] [Abstract][Full Text] [Related]
24. BEST1 expression in the retinal pigment epithelium is modulated by OTX family members.
Esumi N; Kachi S; Hackler L; Masuda T; Yang Z; Campochiaro PA; Zack DJ
Hum Mol Genet; 2009 Jan; 18(1):128-41. PubMed ID: 18849347
[TBL] [Abstract][Full Text] [Related]
25. Differentiation, Maintenance, and Analysis of Human Retinal Pigment Epithelium Cells: A Disease-in-a-dish Model for BEST1 Mutations.
Kittredge A; Ji C; Zhang Y; Yang T
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30199040
[TBL] [Abstract][Full Text] [Related]
26. Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells.
Milenkovic A; Brandl C; Milenkovic VM; Jendryke T; Sirianant L; Wanitchakool P; Zimmermann S; Reiff CM; Horling F; Schrewe H; Schreiber R; Kunzelmann K; Wetzel CH; Weber BH
Proc Natl Acad Sci U S A; 2015 May; 112(20):E2630-9. PubMed ID: 25941382
[TBL] [Abstract][Full Text] [Related]
27. Expression and Purification of Mammalian Bestrophin Ion Channels.
Kittredge A; Ward N; Hopiavuori A; Zhang Y; Yang T
J Vis Exp; 2018 Aug; (138):. PubMed ID: 30124653
[TBL] [Abstract][Full Text] [Related]
28. Restoration of mutant bestrophin-1 expression, localisation and function in a polarised epithelial cell model.
Uggenti C; Briant K; Streit AK; Thomson S; Koay YH; Baines RA; Swanton E; Manson FD
Dis Model Mech; 2016 Nov; 9(11):1317-1328. PubMed ID: 27519691
[TBL] [Abstract][Full Text] [Related]
29. Contribution of Ion Channels in Calcium Signaling Regulating Phagocytosis: MaxiK, Cav1.3 and Bestrophin-1.
Strauß O; Reichhart N; Gomez NM; Müller C
Adv Exp Med Biol; 2016; 854():739-44. PubMed ID: 26427483
[TBL] [Abstract][Full Text] [Related]
30. Nanomedicine-based Curcumin Approach Improved ROS Damage in Best Dystrophy-specific Induced Pluripotent Stem Cells.
Lin TC; Lin YY; Hsu CC; Yang YP; Yang CH; Hwang DK; Wang CY; Liu YY; Lo WL; Chiou SH; Peng CH; Chen SJ; Chang YL
Cell Transplant; 2019 Nov; 28(11):1345-1357. PubMed ID: 31313605
[TBL] [Abstract][Full Text] [Related]
31. Generation of a human induced pluripotent stem cell line, BRCi005-A, derived from a Best disease patient with BEST1 mutations.
Kamata K; Otsuka Y; Imamura K; Oishi A; Kondo T; Suga M; Shibukawa R; Okanishi Y; Sagara Y; Tsukita K; Yasukawa T; Usui H; Muguruma K; Tsujikawa A; Inoue H
Stem Cell Res; 2020 May; 45():101782. PubMed ID: 32416576
[TBL] [Abstract][Full Text] [Related]
32. Pathogenicity of new BEST1 variants identified in Italian patients with best vitelliform macular dystrophy assessed by computational structural biology.
Frecer V; Iarossi G; Salvetti AP; Maltese PE; Delledonne G; Oldani M; Staurenghi G; Falsini B; Minnella AM; Ziccardi L; Magli A; Colombo L; D'Esposito F; Miertus J; Viola F; Attanasio M; Maggio E; Bertelli M
J Transl Med; 2019 Oct; 17(1):330. PubMed ID: 31570112
[TBL] [Abstract][Full Text] [Related]
33. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
[TBL] [Abstract][Full Text] [Related]
34. The role of bestrophin-1 in intracellular Ca(2+) signaling.
Strauß O; Müller C; Reichhart N; Tamm ER; Gomez NM
Adv Exp Med Biol; 2014; 801():113-9. PubMed ID: 24664688
[TBL] [Abstract][Full Text] [Related]
35. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene.
Boon CJ; Klevering BJ; Leroy BP; Hoyng CB; Keunen JE; den Hollander AI
Prog Retin Eye Res; 2009 May; 28(3):187-205. PubMed ID: 19375515
[TBL] [Abstract][Full Text] [Related]
36. Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective.
Dalvi S; Galloway CA; Singh R
Adv Exp Med Biol; 2019; 1186():1-31. PubMed ID: 31654384
[TBL] [Abstract][Full Text] [Related]
37. BEST1: the Best Target for Gene and Cell Therapies.
Yang T; Justus S; Li Y; Tsang SH
Mol Ther; 2015 Dec; 23(12):1805-9. PubMed ID: 26388462
[TBL] [Abstract][Full Text] [Related]
38. Stem cell based therapies for age-related macular degeneration: The promises and the challenges.
Nazari H; Zhang L; Zhu D; Chader GJ; Falabella P; Stefanini F; Rowland T; Clegg DO; Kashani AH; Hinton DR; Humayun MS
Prog Retin Eye Res; 2015 Sep; 48():1-39. PubMed ID: 26113213
[TBL] [Abstract][Full Text] [Related]
39. Induced Pluripotent Stem Cell-Derived Retinal Pigmented Epithelium: A Comparative Study Between Cell Lines and Differentiation Methods.
Leach LL; Croze RH; Hu Q; Nadar VP; Clevenger TN; Pennington BO; Gamm DM; Clegg DO
J Ocul Pharmacol Ther; 2016 Jun; 32(5):317-30. PubMed ID: 27182743
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of Human Protein-Induced Pluripotent Stem Cells toward a Retinal Pigment Epithelial Cell Fate.
Gong J; Fields MA; Moreira EF; Bowrey HE; Gooz M; Ablonczy Z; Del Priore LV
PLoS One; 2015; 10(11):e0143272. PubMed ID: 26606685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
